Brendon Neuen
@brendonneuen
Nephrologist, Associate Professor, Director of Kidney Trials, Royal North Shore Hospital | @NHMRC @GeorgeInstitute Fellow | Secretariat, SMART-C
ID: 25062503
18-03-2009 12:14:59
6,6K Tweet
4,4K Takipçi
1,1K Takip Edilen
Yes agree, Graham Abra, MD - Effects of finerenone in non-diabetic CKD being evaluated in FIND-CKD N=1584 57% GN (417 with IgAN) PEP= total slope over 3 years SEP= 57%⬇️ eGFR, ESKD or renal death Median UACR=819mg/g 17% SGLT2i use at baseline academic.oup.com/ndt/advance-ar…
